Blaize Holdings, Inc. (Nasdaq: BZAI, Nasdaq: BZAIW) (“Blaize,” the “Company,” “we,” “our,” or “us”), a leader in programmable, energy-efficient AI computing, and NeoTensr, a hardware and software system integrator, today announced an up to $50.0 million contract to jointly develop and deploy co-branded AI edge data center infrastructure targeting the rapidly growing compute market across the broader Asia Pacific region.

Enveric Biosciences, Inc. (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company advancing novel neuroplastogenic small-molecule therapeutics to address psychiatric and neurological disorders, today announced that it has entered into definitive agreements for the purchase and sale of 2,222,223 shares of its common stock (or pre-funded warrants in lieu thereof), Series I warrants to purchase up to an aggregate of 2,222,223 shares of common stock and short-term Series J warrants to purchase up to an aggregate of 2,222,223 shares of common stock, at a purchase price of $2.25 per share (or pre-funded warrant in lieu thereof) and accompanying warrants in ...

Schaffung einer Plattform für die Energiewende der nächsten Generation: Die geplante Transaktion vereint SAF, grünes Methanol, erneuerbare Produkte, die Monetarisierung von Umweltattributen und fortschrittliche Energieinfrastruktur in einer einzigen, global skalierbaren Plattform.

HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights, today announced it has closed its underwritten public offering of 12,500,000 shares of common stock for total gross proceeds of $10 million before deducting underwriting discounts, commissions, and offering expenses. The closing of the offering occurred on April 16, 2026.